Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biochemistry

• Publication date

  2015-04-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/bi501486zPMID 25790332PMCID PMC4893950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis.

  2013cited by this paper
• The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.

  2012cited by this paper
• Effects of dalcetrapib in patients with a recent acute coronary syndrome.

  2012cited by this paper
• Influence of C-terminal α-helix hydrophobicity and aromatic amino acid content on apolipoprotein A-I functionality.

  2012cited by this paper
• Apolipoprotein E Mediates Enhanced Plasma High-Density Lipoprotein Cholesterol Clearance by Low-Dose Streptococcal Serum Opacity Factor via Hepatic Low-Density Lipoprotein Receptors In Vivo

  2011cited by this paper
• Influence of Apolipoprotein A-I Domain Structure on Macrophage Reverse Cholesterol Transport in Mice

  2011cited by this paper
• Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort.

  2011cited by this paper
• Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol.

  2010cited by this paper
• Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature.

  2010cited by this paper
• Marked HDL deficiency and premature coronary heart disease

  2010cited by this paper
• Streptococcal serum opacity factor activity enhances reverse cholesterol transport in vitro

  2010cited by this paper
• Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

  2009cited by this paper
• Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.

  2009cited by this paper
• Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.

  2009cited by this paper
• The Vote of Acute Medical Inpatients

  2009cited by this paper
• COMPLETE APO AI DEFICIENCY IN A FAMILY FROM IRAQ

  2008cited by this paper
• Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency1 Published, JLR Papers in Press, November 8, 2007.

  2008cited by this paper
• Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.

  2007cited by this paper
• Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.

  2007cited by this paper
• A unique role?

  2007cited by this paper
• What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport?

  2006cited by this paper
• The unique role of apolipoprotein A-I in HDL remodeling and metabolism.

  2006cited by this paper
• Kinetic stabilization and fusion of apolipoprotein A-2:DMPC disks: comparison with apoA-1 and apoC-1.

  2005cited by this paper
• Human plasma high-density lipoproteins are stabilized by kinetic factors.

  2003cited by this paper
• ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL.

  2002cited by this paper
• Formation of Spherical, Reconstituted High Density Lipoproteins Containing Both Apolipoproteins A-I and A-II Is Mediated by Lecithin:Cholesterol Acyltransferase*

  2000cited by this paper
• Serum opacity factor is a major fibronectin‐binding protein and a virulence determinant of M type 2 Streptococcus pyogenes

  1999cited by this paper
• Molecular and macromolecular specificity of human plasma phospholipid transfer protein.

  1997cited by this paper
• Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase.

  1996cited by this paper
• The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.

  1996cited by this paper
• Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.

  1993cited by this paper
• Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.

  1992cited by this paper
• Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL.

  1992cited by this paper
• Lipid transfer particle-induced transformation of human high density lipoprotein into apolipoprotein A-I-deficient low density particles.

  1990cited by this paper
• Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

  1988cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II.

  1982cited by this paper
• Factors affecting the integrity of high density lipoproteins in the ultracentrifuge.

  1982cited by this paper
• In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II.

  1980cited by this paper
• HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study

  1977cited by this paper

• Highly Conserved Amino Acid Residues in Apolipoprotein A1 Discordantly Induce High Density Lipoprotein Assembly In Vitro and In Vivo.

  2020cites this paper
• Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.

  2019cites this paper
• Structural Stability of Streptococcal Serum Opacity Factor

  2017cites this paper
• Comparative proteome analysis of abdominal adipose tissues between fat and lean broilers

  2016cites this paper
• Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo.

  2016cites this paper
• Characterization of oxysterols produced in macrophages and mechanisms of regulation

  2016cites this paper